Cardiac conduction alterations in a French family with amyloidosis of the Finnish type with the p.Asp187Tyr mutation in the GSN gene

Muscle and Nerve

Volumn 33, Issue 1, 2006, Pages 113-119

  Chastan, Nathalie ^a   Baert Desurmont, Stéphanie ^a,b   Saugier Veber, Pascale ^a,b   Dérumeaux, Geneviève ^a   Cabot, Annick ^a   Frébourg, Thierry ^a,b   Hannequin, Didier ^a,b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Amyloid; Cardiac conduction; Familial amyloidosis of Finnish type; Gelsolin; Mutation p.Asp187Tyr

Indexed keywords

ASPARTIC ACID; GENOMIC DNA; TYROSINE;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BLEPHAROCHALASIS; CARPAL TUNNEL SYNDROME; CASE REPORT; CLINICAL FEATURE; CRANIAL NEUROPATHY; DYSPHAGIA; ELECTROMYOGRAPHY; FAMILIAL AMYLOIDOSIS; FEMALE; FRANCE; GENE; GENE MUTATION; GENE SEQUENCE; GSN GENE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; MALE; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PARESTHESIA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SYMPTOM; SYNCOPE;

AGED; AMYLOIDOSIS, FAMILIAL; ARRHYTHMIA; ASPARTIC ACID; FACIES; FRANCE; GELSOLIN; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; PEDIGREE; POINT MUTATION; TONGUE; TYROSINE;

EID: 30344467836     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20448     Document Type: Article

References (39)

1. Akiya S, Nishio Y, Ibi K, Uozumi H, Takahashi H, Hamada T, et al. Lattice corneal dystrophy type II associated with familial amyloid polyneuropathy type IV. Ophthalmology 1996;103: 1106-1110.
2. Boysen G, Galassi G, Kamieniecka Z, Schlaeger J, Trojaborg W. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. J Neurol Neurosurg Psychiatry 1979;42: 1020-1030.
3. 2+ stabilization. EMBO J 2001;20:6277-6287.
4. Conceiççāo I, Sales-Luis ML, De Carvalho M, Evangelista T, Fernandes R, Paunio T, et al. Gelsolin-related familial amyloidosis, Finnish type, in a Portuguese family: clinical and neurophysiological studies. Muscle Nerve 2003;28:715-721.
5. Darras BT, Adelman LS, Mora JS, Bodziner RA, Munsat TL. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. Neurology 1986;36:432-435.
6. De la Chapelle A, Tolvanen R, Boysen G, Santavy J, Bleeker-Wagemakers L, Maury CPJ, et al. Gelsolin derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187, Nat Genet 1992;2:157-160.
7. De la Chapelle A, Kere J, Sack GH, Tolvanen R, Maury CPJ. Familial amyloidosis, Finnish-type: G654 → A mutation of the gelsolin gene in Finnish families and an unrelated American family. Genomics 1992;13:898-901.
8. Fernandez AL, Herreros JM, Monzonis AM, Panizo A. Heart transplantation for Finnish type familial systemic amyloidosis. Scand Cardiovasc J 1997;31:357-359.
9. Gorevic PD, Munoz PC, Gorgone G, Purcell JJ, Rodrigues M, Ghiso J, et al. Amyloidosis due to a mutation of the gelsolin gene in an American family with lattice corneal dystrophy type II. N Engl J Med 1991;325:1780-1785.
10. Haltia M, Prelli F, Ghiso J, Kiuru S, Somer H, Palo J, et al. Amyloid protein in familial amyloidosis (Finnish type) is homologous to gelsolin, an actin-binding protein. Biochem Biophys Res Commun 1990;167:927-932.
11. Haltia M, Ghiso J, Prelli F, Gallo G, Kiuru S, Somer H, et al. Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol 1990;136: 1223-1228.
12. Haltia M, Levy E, Meretoja J, Fernandez-Madrid I, Koivunen O, Frangione B. Gelsolin gene mutation, at codon 187, in familial amyloidosis, Finnish: DNA-diagnostic assay. Am J Med Genet 1992;42:357-359.
13. 187 → Asn mutation of gelsolin with the disease in three large families. Am J Hum Genet 1991;49:522-528.
14. Isaacson RL, Weeds AG, Fersht AR. Equilibria and kinetics of folding of gelsolin domain 2 and mutants involved in familial amyloidosis-Finnish type. Proc Natl Acad Sci USA 1999;96: 11247-11252.
15. Kazmirski SL, Howard MJ, Isaacson RL, Fersht AR. Elucidating the mechanism of familial amyloidosis-Finnish type: NMR studies of human gelsolin domain 2. Proc Natl Acad Sci USA 2000;97:10706-10711.
16. Kazmirski SL, Isaacson RL, An C, Buckle A, Johnson CM, Daggett V, et al. Loss of a metal-binding site in gelsolin leads to familial amyloidosis-Finnish type. Nat Struct Biol 2002;9: 112-116.
17. Kiuru S. Familial amyloidosis of the Finnish type (FAF). A clinical study of 30 patients. Acta Neurol Scand 1992;86:346-353.
18. Kiuru S, Matikainen E, Kupari M, Haltia M, Palo J. Autonomic nervous system and cardiac involvement in familial amyloidosis, Finnish type (FAF). J Neurol Sci 1994;126:40-48.
19. Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worlwide. Amyloid 1998;5:55-66.
20. Klaus E, Freyberger E, Kavka G, Vodicka F. Familiäres vorkommen von bulbärparalytischer form der amyotrophischen lateralsklerose mit gittriger hornhautdystrophie und cutis hyperlastica bei drei schwestern. Psychiat Neurol 1959; 138:79-97.
21. Levy E, Haltia M, Fernandez-Madrid I, Koivunen O, Ghiso J, Prelli F, et al. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med 1990;172:1865-1867.
22. Makishita H, Yazaki M, Matsuda M, Ikeda S, Yanagisawa N. Familial amyloid polyneuropathy type IV (Finnish-type). A clinicopathological study. Rinsho Shinkeigaku 1994;34:431-437.
23. Maury CPJ, Alli K, Baumann M. Finnish hereditary amyloidosis. Amino acid sequence homology between the amyloid fibril protein and human plasma gelsoline. FEBS Lett 1990; 260:85-87.
24. Maury CPJ. Gelsolin-related amyloidosis. Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin. J Clin Invest 1991;87:1195-1199.
25. Maury CPJ, Kere J, Tolvanen R, De la Chapelle A. Homozygosity for the Asn187 gelsolin mutation in Finnish-type familial amyloidosis in associated with severe renal disease. Genomics 1992;13:902-903.
26. Maury CPJ, Sletten K, Totty N, Kangas H, Liljestrom M. Identification of the circulating amyloid precursor and other gelsolin metabolites in patients with G654A mutation in the gelsolin gene (Finnish familial amyloidosis): pathogenetic and diagnostic implications. Lab Invest 1997;77:299-304.
27. Maury CPJ, Liljestrom M, Boysen G, Tornroth T, De la Chapelle A, Nurmiaho-Lassila EL. Danish type gelsolin related amyloidosis: 654G-T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G-A mutation (familial amyloidosis of the Finnish type). J Clin Pathol 2000;53:95-99.
28. Maury CPJ, Nurmiaho-Lassila EL, Boysen G, Liljestrom M. Fibrillogenesis in gelsolin-related familial amyloidosis. Amyloid 2003;10(Suppl 1):21-25.
29. Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. Ann Clin Res 1969;1:314-324.
30. Paunio T, Kiuru S, Hongell V, Mustonen E, Syvanen AC, Bengtstrōm M, et al. Solid-phase minisequencing test reveals Asp187 → Asn (G654 → A) mutation of gelsolin in all affected individuals with Finnish type of familial amyloidosis. Genomics 1992;13:237-239.
31. Paunio T, Sunada Y, Kiuru S, Makishita H, Ikeda SI, Weissenbach J, et al. Haplotype analysis in gelsolin-related amyloidosis reveals independent origin of identical mutation (G654A) of gelsolin in Finland and Japan. Hum Mutat 1995;6:60-65.
32. Purcell JJ Jr, Rodrigues M, Chishti MI, Riner RN, Dooley JM. Lattice corneal dystrophy associated with familial systemic amyloidosis (Meretoja's syndrome). Ophthalmology 1983;90: 1512-1517.
33. Sack GH Jr, Dumars KW, Gummerson KS, Law A, McKusick VA. Three forms of dominant amyloid neuropathy. Johns Hopkins Med J 1981;149:239-247.
34. Starck T, Kenyon KR, Hanninen LA, Beyer-Machule C, Fabian R, Corn RA, et al. Clinical and histopathologic studies of two families with lattice corneal dystrophy and familial systemic amyloidosis (Meretoja syndrome). Ophthalmology 1991;98: 1197-1206.
35. Steiner RD, Paunio T, Uemichi T, Evans JP, Benson MD. Asp187Asn mutation of gelsolin in an American kindred with familial amyloidosis, Finnish type (FAP IV). Hum Genet 1995; 95:327-330.
36. Stewart HS, Parveen R, Ridgway AE, Bonshek R, Black GC. Late onset lattice corneal dystrophy with systemic familial amyloidosis, amyloidosis V, in an English family. Br J Ophtalmol 2000;84:390-394.
37. Sunada Y, Nakase H, Shimizu T, Mannen T, Kanazawa I. Gene analysis of Japanese patients with familial amyloidotic polyneuropathy type IV. Rinsho Shinkeigaku 1992;32:840-844.
38. Sunada Y, Shimizu T, Nakase H, Ohta S, Asaoka T, Amano S, et al. Inherited amyloid polyneuropathy type IV (gelsolin variant) in a Japanese family. Ann Neurol 1993;33:57-62.
39. Winkelman JE, Delleman JW, Ansink BJJ. Ein hereditāres syndrom, bestehend aus peripherer polyneuropathie, hautveränderungen und gittrigen dystrophie der hornhaut. Klin MbI Augenheilk 1971;159:618-623.